Psoriasis (PsO)
Immunology·MeSH: Psoriasis
Prevalence
3000.0 / 100K
Incidence
78.0 / 100K/yr
4 drugs in development·4 companies·2 clinical trials
Drug Pipeline by Phase
Approved(3)
Phase 3(1)
| Drug | Company |
|---|---|
| ESK-001 | ALUMIS INC. (ALMS) |
Compare drugs
Frequently asked questions
How many drugs are in development for Psoriasis (PsO)?
BioSniper tracks 4 drugs in development for Psoriasis (PsO) across 4 companies.
How many clinical trials target Psoriasis (PsO)?
There are 2 clinical trials targeting Psoriasis (PsO) tracked by BioSniper.
What is the prevalence of Psoriasis (PsO)?
The estimated prevalence of Psoriasis (PsO) is approximately 3000.0 per 100,000 population.
Deep-dive into Psoriasis (PsO)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis